Ar
Non vérifié

Ardena Holding NV.

Ce que nous écrivons

Annonces ÉconomiquesIndustrie pharmaceutiqueManagement/Organisation d'EntrepriseMédecine Santé Bien-êtrePublicité/Marketing/Médias/Communication
01/06/2026
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Ardena appoints Ariane de Ganck as Chief Scientific Officer
1.00
04/05/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
1.00
15/04/2026
Industrie pharmaceutique
Annonces Économiques
Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey
1.00
02/03/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Ardena Appoints Paul Edwards as Chief People Officer
1.00
29/01/2026
Industrie pharmaceutique
Médecine Santé Bien-être
Management/Organisation d'Entreprise
Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica
1.00
03/11/2025
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Ardena strengthens executive leadership with appointments of Chief Quality Officer and Chief Information Officer
1.00
04/02/2025
Industrie pharmaceutique
Annonces Économiques
Médecine Santé Bien-être
Publicité/Marketing/Médias/Communication
Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America
1.00
19/11/2024
Industrie pharmaceutique
Annonces Économiques
Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing
1.00
29/10/2024
Industrie pharmaceutique
Annonces Économiques
Ardena Expands Bioanalytical Services in Europe
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0